Silybin has therapeutic efficacy against non-small cell lung cancer through targeting of Skp2

• Main Authors: Shi-Bing Zhang (Author), Ming Hong (Author), Xiao-Yang Sun (Author), Da Huang (Author), Dan-Hua He (Author), Yu-Fei Chen (Author), Yong Yuan (Author), Yong-Qiang Liu (Author)
• Format: Book
• Published: Compuscript Ltd, 2022-08-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Silybin (SB), a natural flavonoid isolated from Silybum marianum, has been used to treat hepatic fibrosis in clinical settings and as a dietary supplement, because of its hepatoprotective potential. Numerous studies have shown that SB also exerts promising anticancer effects; however, the anticancer...